Extended-Release Naltrexone for Alcohol Dependence: Persistence and Healthcare Costs and Utilization

2011 
Objective Evaluate persistence with treatment, healthcare costs, and utilization in stably enrolled Aetna Behavioral Health members receiving extended-release naltrexone (XR-NTX) for alcohol use dependence compared with oral medications and psychosocial therapy only.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    22
    Citations
    NaN
    KQI
    []